Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2660)
All Articles published online
|
Mar 21, 2008 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Arbuthnot P, Thompson LJ. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1670-1681 [PMID: 18350598 DOI: 10.3748/wjg.14.1670] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1670.htm |
| Number | Citing Articles |
| 1 |
Jennifer Louten, Michael Beach, Kristina Palermino, Maria Weeks, Gabrielle Holenstein. MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations. Biomarker Insights 2015; : BMI.S29512 doi: 10.4137/BMI.S29512
|
| 2 |
Tracey M. Hinton, Paul Monaghan, Diane Green, Sander A.A. Kooijmans, Shuning Shi, Kerry Breheney, Mark Tizard, Joseph A. Nicolazzo, Alexander N. Zelikin, Kim Wark. Biodistribution of polymer hydrogel capsules for the delivery of therapeutics. Acta Biomaterialia 2012; 8(9): 3251 doi: 10.1016/j.actbio.2012.05.028
|
| 3 |
N. Manjunath, Haoquan Wu, Sandesh Subramanya, Premlata Shankar. Lentiviral delivery of short hairpin RNAs. Advanced Drug Delivery Reviews 2009; 61(9): 732 doi: 10.1016/j.addr.2009.03.004
|
| 4 |
S M Metias, E Lianidou, G M Yousef. MicroRNAs in clinical oncology: at the crossroads between promises and problems. Journal of Clinical Pathology 2009; 62(9): 771 doi: 10.1136/jcp.2009.064717
|
| 5 |
Bo Yu, Shu-Hao Hsu, Chenguang Zhou, Xinmei Wang, Megan C. Terp, Yun Wu, Lesheng Teng, Yicheng Mao, Feng Wang, Weiming Xue, Samson T. Jacob, Kalpana Ghoshal, Robert J. Lee, Ly J. Lee. Lipid nanoparticles for hepatic delivery of small interfering RNA. Biomaterials 2012; 33(25): 5924 doi: 10.1016/j.biomaterials.2012.05.002
|
| 6 |
Betsy T. Kren, Clifford J. Steer, Namita Roy Chowdhury, Jayanta Roy Chowdhury. The Liver. 2009; : 965 doi: 10.1002/9780470747919.ch59
|
| 7 |
|
| 8 |
Song He, Ying-ze Wei, Gui-lan Wang, Yu-yin Xu, Jia-ming Zhou, Yi-xin Zhang, Li Chen. Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma TherapyIn VitroandIn Vivo. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/685150
|
| 9 |
Gray Kueberuwa, Ryan Cawood, Alison Tedcastle, Leonard W. Seymour. Tissue-Specific Attenuation of Oncolytic Sindbis Virus Without Compromised Genetic Stability. Human Gene Therapy Methods 2014; 25(2): 154 doi: 10.1089/hgtb.2013.202
|
| 10 |
Mohube Betty Mowa, Carol Crowther, Patrick Arbuthnot. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators. Expert Opinion on Drug Delivery 2010; 7(12): 1373 doi: 10.1517/17425247.2010.533655
|
| 11 |
Dejana Ivacik, Abdullah Ely, Patrick Arbuthnot. Countering hepatitis B virus infection using RNAi: how far are we from the clinic?. Reviews in Medical Virology 2011; 21(6): 383 doi: 10.1002/rmv.705
|
| 12 |
G. Gonzalez-Aseguinolaza, J. Prieto, R. Hernandez-Alcoceba. Gene therapy of liver cancer: an update. Journal Africain du Cancer / African Journal of Cancer 2011; 3(3): 180 doi: 10.1007/s12558-011-0153-1
|
| 13 |
Xueling Ren, Yue Ma, Min Xu, Tingting Chen, Zhenzhong Zhang, Yun Zhang. Construction, modification and evaluation of apolipoprotein A-I promoter-driven shRNA expression vectors against hTERT. Plasmid 2011; 65(1): 42 doi: 10.1016/j.plasmid.2010.11.001
|
| 14 |
Meng Zhao, Hong-wei He, Huan-xing Sun, Kai-huan Ren, Rong-guang Shao. Dual knockdown of N-ras and epiregulin synergistically suppressed the growth of human hepatoma cells. Biochemical and Biophysical Research Communications 2009; 387(2): 239 doi: 10.1016/j.bbrc.2009.06.128
|
| 15 |
Patrick Arbuthnot. MicroRNA-like antivirals. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2011; 1809(11-12): 746 doi: 10.1016/j.bbagrm.2011.05.006
|
| 16 |
Mathieu Bergé, Philippe Bonnin, Eric Sulpice, José Vilar, David Allanic, Jean-Sébastien Silvestre, Bernard I. Lévy, Gordon C. Tucker, Gérard Tobelem, Tatyana Merkulova-Rainon. Small Interfering RNAs Induce Target-Independent Inhibition of Tumor Growth and Vasculature Remodeling in a Mouse Model of Hepatocellular Carcinoma. The American Journal of Pathology 2010; 177(6): 3192 doi: 10.2353/ajpath.2010.100157
|
| 17 |
David J. Pinato, Mario Pirisi, Lynn Maslen, Rohini Sharma. Tissue Biomarkers of Prognostic Significance in Hepatocellular Carcinoma. Advances in Anatomic Pathology 2014; 21(4): 270 doi: 10.1097/PAP.0000000000000029
|
| 18 |
Qing Ge, John J Xu, David M Evans, A James Mixson, Harry Y Yang, Patrick Y Lu. Leveraging Therapeutic Potential of Multi-Targeted Sirna Inhibitors. Future Medicinal Chemistry 2009; 1(9): 1671 doi: 10.4155/fmc.09.131
|
| 19 |
Tingting Zhu, Ziwei Cheng, Xiaolin Peng, Dongwei Xing, Minguang Zhang, Francesca Mancianti. HIF-1α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/9987383
|
| 20 |
Clifford J. Steer, Betsy T. Kren. The Future of Aging. 2010; : 641 doi: 10.1007/978-90-481-3999-6_21
|
| 21 |
H.M. El Tayebi, K.A. Hosny, G. Esmat, K. Breuhahn, Ahmed Ihab Abdelaziz. miR‐615‐5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma. FEBS Letters 2012; 586(19): 3309 doi: 10.1016/j.febslet.2012.06.054
|
| 22 |
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, Hashem O. Alsaab. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA. Cell Biochemistry and Biophysics 2024; 82(3): 1947 doi: 10.1007/s12013-024-01395-6
|
| 23 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 24 |
Lanxia Liu, Hai Wang, Qi Liu, Mingli Duan, Xia Dong, Dunwan Zhu, Yingjun Zhu, Xigang Leng. Biodistribution of TAT‐LHRH conjugated chitosan/DNA nanoparticles in the mice bearing hepatoma xenografts. Journal of Biomedical Materials Research Part A 2016; 104(10): 2394 doi: 10.1002/jbm.a.35775
|
| 25 |
Krishna K. Banaudha, Mukesh Verma. Cancer Epigenetics. Methods in Molecular Biology 2012; 863: 241 doi: 10.1007/978-1-61779-612-8_14
|
| 26 |
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptide. Drug Delivery and Translational Research 2017; 7(1): 147 doi: 10.1007/s13346-016-0348-1
|
| 27 |
Yan Li, Zhao-You Tang, Jin-Xuan Hou. Hepatocellular carcinoma: insight from animal models. Nature Reviews Gastroenterology & Hepatology 2012; 9(1): 32 doi: 10.1038/nrgastro.2011.196
|